Maes, B <br/><br/>
Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jun 2001 
 - 853-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1023/a:1011195708834  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anaplastic Lymphoma Kinase<br/>B-Lymphocyte Subsets--pathology<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunophenotyping<br/>Ki-1 Antigen--analysis<br/>Lymphocytes, Null--pathology<br/>Lymphoma, B-Cell--classification<br/>Lymphoma, Large B-Cell, Diffuse--classification<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Protein-Tyrosine Kinases--analysis<br/>Receptor Protein-Tyrosine Kinases<br/>Survival Rate<br/>T-Lymphocytes--pathology